Regeneron Pharmaceuticals (REGN) Dividends Paid - Common (2025 - 2026)
Regeneron Pharmaceuticals (REGN) posted quarterly Dividends Paid - Common of $96.8 million for Q2 2026, up 4.54% year-over-year from $92.6 million in Q2 2025, and down 1.02% quarter-over-quarter from $97.8 million in Q1 2026.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Dividends Paid - Common (2025 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Dividends Paid - Common history runs 2 years deep, the most recent figure standing at $96.8 million for Q2 2026.
- In Q2 2026, Dividends Paid - Common rose 4.54% year-over-year to $96.8 million; the TTM figure through Jun 2026 stood at $378.5 million (up 103.06% YoY), while the FY2025 annual figure was $370.3 million, changed N/A from the prior year.
- Dividends Paid - Common for Q2 2026 stood at $96.8 million, down from $97.8 million in the prior quarter.
- The five-year high for Dividends Paid - Common was $97.8 million in Q1 2026, with the low at $91.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 34.60 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.80 Mn |
| Mar 31, 2026 | 97.80 Mn |
| Dec 31, 2025 | 92.70 Mn |
| Sep 30, 2025 | 91.20 Mn |
| Jun 30, 2025 | 92.60 Mn |
| Mar 31, 2025 | 93.80 Mn |